We recently published a list of 10 Surprising Stocks That Skyrocketed Today. In this article, we are going to take a look at ...

Acadia Pharmaceuticals ACAD shares surged 26.5% on Friday after the company announced that the U.S. District Court in ...

Acadia Pharmaceuticals strengthens Nuplazid's IP, anticipates stabilization in commercial performance, and eyes future ...

ACADIA Pharmaceuticals shares gained 26.5% to close at $22.26 on Friday. These analysts made changes to their price targets ...

A six-month programme, the CLP aims to transform promising professionals into dynamic leaders by equipping them with skills ...

Acadia Pharma gets favourable ruling from Delaware District Court in Nuplazid formulation patent litigation: San Diego Monday, May 19, 2025, 17:00 Hrs [IST] Acadia Pharmaceuticals ...

Hyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has obtained marketing ...

With the stock correcting 12-13% over the past six months, current valuations appear attractive, brokerage firm Motilal Oswal ...

With the stock currently trading at Rs 1141.50, Aurobindo Pharma has experienced a notable decline in today's session.

Aurobindo Pharma, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1217. The stock has experienced fluctuations today ...

Aurobindo’s wholly owned subsidiary, Eugia Pharma Specialities, has received the Food and Drug Administration’s permission to ...

Post-Graduation Certification in Leadership program by Aurobindo Pharma & IMT Hyderabad for middle managers' growth." ...